Latest news with #Minter
New York Post
6 days ago
- Politics
- New York Post
Democrats' criminal-justice lies are as awful as the Biden coverup
Last week, former President Joe Biden disclosed his inexplicably 'undetected' aggressive cancer as bombshell revelations detailed how the White House covered up his crumbling health — enabled by a media establishment that hid the uncomfortable truth. Americans are outraged that supposedly trustworthy institutions lied about facts we needed to choose a president. We should be equally furious at the lies that officials and the progressive press have told us about public safety and 'justice reform' laws built on false narratives. Advertisement 'Our criminal justice system must be focused on redemption and rehabilitation,' Biden asserted during his 2020 presidential campaign. He pledged to 'reduce the number of people incarcerated' and, fantastically, to 'root out the racial, gender, and income-based disparities in the system' — ideals that New York Democrats also followed. Advertisement The words are as empty as the assurances of Biden's fitness were. In truth, about 35% of serious offenders are re-arrested within a year of prison release, with 85% re-arrested over a decade. No wonder reforms that replaced criminal consequences with social services boosted crime and reduced accountability. Tragically, when our government hides such truths, innocent people get hurt. Advertisement In 2023, for example, when Tyresse Minter was paroled early to the Bronx home of his wife Karen, the family was not warned that even while incarcerated (for pistol-whipping a man and then shooting him three times in the back), Minter had been disciplined for violent conduct and possessing a weapon. Karen was further lulled by the parenting and anger-management classes mandated for Minter by Family Court, led to believe that enrollment equaled rehabilitation. One month after she took Minter in, he fatally strangled Karen's 15-year-old son, Corde Scott. 'He was paroled to my home,' Karen told me. Advertisement 'So, they thought it was safe . . . Safe for who? He killed Corde.' New York's 2019 bail 'reform' law similarly refused to grapple with dangerousness — based on narratives about 'mass incarceration' and 'systemic racism.' Judges now are barred from setting bail for hundreds of offenses, forcing them to release even defendants who pose a clear threat to public safety. No wonder New Yorkers continue to feel unsafe in the subways, despite increased police presence: They no longer trust a criminal justice system that literally can't detain a violent psycho after he's committed an assault and swears to commit more. New York's discovery 'reform,' also built on baloney narratives about over-incarceration and race, forced prosecutors to simply decline or dismiss tens of thousands of cases rather than convict guilty criminals. Of course Gotham's pharmacies are locking up more and more products: They rightly don't trust the justice system to keep recidivists out of their shampoo aisles. Statewide 'Raise the Age' is perhaps the most appallingly deceitful 'reform' of all, because it endangers kids. Advertisement By removing criminal consequences for 16- and 17-year-olds, even when they commit repeated acts of violence, the law forces NYC teens to live in fear of their peers — a reality only worsened by 'Raise the Lower Age,' which prevents officers from taking kids under age 12 into custody at all. Juvenile probation and youth officers lament that more kids are bringing knives and guns to school because they correctly do not trust the system to protect them from dangerous classmates. By continually forgiving teen violence and burying case records, the laws have actually empowered violent youths to be more violent. In the last half-decade, NYC youth arrests surged up 68%, and youth victimization jumped 71%. Advertisement Nor can the city's vulnerable children trust the Administration for Children's Services to keep dangerous parents from harming them. Fallacious narratives about racial disparity and the stigma of criminal investigations lead ACS to channel 70% of neglect and abuse cases toward social service responses — not actual investigations. At least seven children have died in the past year under caseworkers' unserious 'supervision.' ACS has shown itself to be so untrustworthy that the city Department of Investigations is pushing for license to review at least a dozen recent child-harm cases. Advertisement Clearly, DOI doesn't trust the agency to decide which abuse claims are 'unfounded.' To regain trust in our institutions, New Yorkers must bring back mechanisms that force agencies to 'show us the receipts' when it comes to dangerous criminals. That means revising the bail law to permit judges to consider dangerousness in detaining offenders pre-trial, and amending the discovery law (beyond the recent tweaks) to ensure all cases with merit can be robustly prosecuted. Advertisement We must fix 'Raise the Age' and 'Raise the Lower Age' to re-establish real criminal consequences for youth violence — and to disclose statistics on young offenders. And ACS should return to actually investigating abusive parents. It's up to citizens to demand institutional honesty by pushing for policies based on truth, not pretty lies about redemption and race. Hannah E. Meyers is a fellow and the director of policing and public safety at the Manhattan Institute.
New York Post
09-05-2025
- Sport
- New York Post
Mets' A.J. Minter eyes healthy 2026 after ‘frustrating' season-ending lat injury
Access the Mets beat like never before Join Post Sports+ for exciting subscriber-only features, including real-time texting with Mike Puma about the inside buzz on the Mets. Try it free The Mets will be without A.J. Minter for the rest of this season and perhaps into next year, with the left-hander set for surgery to repair a torn lat. Minter, speaking for the first time Friday since making the decision to undergo surgery next week, said the procedure comes with a 10-12 month rehab process. Advertisement If all goes well, Minter said he could have a 'normal-ish' spring training and then not be far off when the regular season begins. But he also noted the surgery — necessary because he tore the lat off the bone on April 26 against the Nationals — is rare, so there's not much information to go off of. The 31-year-old signed a two-year, $22 million deal with the Mets in the offseason that contains an opt-out after this year. 3 Mets pitcher A.J. Minter (33) throws in the eighth inning against the St. Louis Cardinals at Citi Field on Saturday, April 19, 2025. Corey Sipkin for the NY POST Advertisement Minter's season ended with Atlanta last year with hip surgery in August. He called the injury 'super frustrating.' 'I was starting to feel so good,'' said Minter, who hadn't given up a run in his previous 12 appearances and struck out 13 batters in 10 innings during that stretch. 'I wish I knew what caused it.' Advertisement CHECK OUT THE LATEST MLB STANDINGS AND METS STATS He pointed to an increase in velocity and added range of motion in his hip as possibilities, but Minter's main focus, he said, is getting healthy for 2026. 'I was excited to help this team,' Minter said. 'It's a special team. I'll help this team next year.' 3 Mets pitcher A.J. Minter (33) reacts in the eighth inning against the St. Louis Cardinals at Citi Field on Saturday, April 19, 2025, in Queens, NY. Corey Sipkin for the NY POST Advertisement Minter's injury, coupled with Danny Young's Tommy John surgery, leaves the Mets with just one lefty in the pen, Genesis Cabrera. Mark Vientos sat for a second straight game, with Mendoza saying he wanted as many left-handed hitters in the lineup against Cubs right-hander Jameson Taillon. Mendoza said Jeff McNeil would have started in center field if he hadn't a hamstring cramp Wednesday. So McNeil served as the DH, with fellow lefty hitter Brett Baty at third base for two consecutive games and Vientos on the bench again. The Mets injured starting pitchers are getting closer to a return, with lefty Sean Manaea (oblique) ready to play catch off a mound and up to 120 feet and right-hander Frankie Montas preparing to face hitters in live batting practice in about a week for the first time since suffering a lat strain. 3 Sean Manaea looks for a fan to throw a ball to at Citi Field. JASON SZENES/ NY POST Paul Blackburn is scheduled to start for Triple-A Syracuse Sunday and is 'progressing well,' Mendoza said. Advertisement The right-hander — sidelined with right knee inflammation — is being built up to 70-75 pitches before he returns to the rotation. Mendoza pointed to Juan Soto 'maybe not hitting as many balls on the ground as earlier' as one of the reasons his numbers have begun to return to normal. Soto entered Friday in the midst of a seven-game stretch in which he's gone 9-for-26, with six extra-base hits (two doubles and four homers) with six walks in his last 33 plate appearances. Advertisement 'He's a special hitter,' the manager said. 'We knew at some point it was gonna turn around. … He's using the whole field and getting the ball off the ground a little more.' Ronny Mauricio will have to wait until Saturday to play his first game with Double-A Binghamton after Friday's game was canceled because of inclement weather. Binghamton is set to play Reading on Saturday. Advertisement In five games with Class-A St. Lucie, Mauricio, on a rehab assignment from a torn ACL suffered playing winter ball two offseasons ago, went 2-for-15 with a pair of stolen bases and played second base, third and shortstop. MLB announced Friday that Francisco Lindor was credited with a stolen base from Wednesday's game after the play was originally ruled defensive indifference. And an error charged to Pete Alonso on Monday was changed to a hit for Arizona's Alek Thomas.
Business Insider
09-05-2025
- Business
- Business Insider
Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (DH) and Silence Therapeutics (SLN)
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Definitive Healthcare Corp (DH – Research Report) and Silence Therapeutics (SLN – Research Report) with bullish sentiments. Protect Your Portfolio Against Market Uncertainty Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter. Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox. Definitive Healthcare Corp (DH) In a report released today, Ryan Daniels from William Blair maintained a Buy rating on Definitive Healthcare Corp. The company's shares closed last Thursday at $2.81, close to its 52-week low of $2.55. According to Daniels is a 4-star analyst with an average return of 7.7% and a 49.6% success rate. Daniels covers the Healthcare sector, focusing on stocks such as Lifestance Health Group, Pediatrix Medical Group, and Alignment Healthcare. The word on The Street in general, suggests a Hold analyst consensus rating for Definitive Healthcare Corp with a $4.57 average price target. Silence Therapeutics (SLN) William Blair analyst Myles Minter maintained a Buy rating on Silence Therapeutics today. The company's shares closed last Thursday at $3.56, close to its 52-week low of $3.19. According to Minter is a 4-star analyst with an average return of 5.0% and a 48.6% success rate. Minter covers the Healthcare sector, focusing on stocks such as CAMP4 Therapeutics Corporation, Neumora Therapeutics, Inc., and Entrada Therapeutics Inc.
Business Insider
07-05-2025
- Business
- Business Insider
William Blair Keeps Their Buy Rating on Denali Therapeutics (DNLI)
In a report released today, Myles Minter from William Blair reiterated a Buy rating on Denali Therapeutics (DNLI – Research Report). The company's shares closed yesterday at $13.97. Protect Your Portfolio Against Market Uncertainty Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter. Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox. According to TipRanks, Minter is a 4-star analyst with an average return of 5.0% and a 48.62% success rate. Minter covers the Healthcare sector, focusing on stocks such as Axsome Therapeutics, Alnylam Pharma, and Arcturus Therapeutics. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Denali Therapeutics with a $39.00 average price target.
New York Times
04-05-2025
- Sport
- New York Times
Mets' lefty Danny Young to have Tommy John surgery: Source
NEW YORK — The Mets have lost their second lefty reliever, this one for the season. Danny Young will undergo Tommy John surgery and miss the remainder of 2025 and into the 2026 season, according to a league source. Young landed on the injured list Wednesday and was transferred to the 60-day injured list Sunday. After soreness in his left forearm had inhibited his recovery process over the first few weeks of the season, Young underwent an MRI on Wednesday morning that showed a left elbow sprain. After consultation with additional doctors, Young and the Mets decided on surgery. Advertisement Young appeared in 10 games this season, pitching to a 4.32 ERA with 13 strikeouts in 8 1/3 innings. Young, who turns 31 later this month, emerged last season as a contributing piece in New York's rebuilt bullpen, eventually becoming their primary lefty out of the pen down the stretch. Young had served as the second lefty this season behind A.J. Minter, though that role was about to expand given Minter's extended absence. The Mets lost Minter, their primary lefty in the bullpen, last Sunday. Surgery is also on the table for Minter, which would cost him the season as well. 'This is about as bad a timing as you can get,' Young said Wednesday night, before any decision on surgery had been made. 'It's unfortunate. I obviously want to pick up the slack. This is the situation we're in now.' The Mets did re-sign Brooks Raley, and he could become a factor by the second half of the season. Raley was their primary left-handed reliever last season before requiring Tommy John surgery in late May. In the meantime, the Mets plan to give their late-game chances against lefties to their current crop of high-leverage relievers. That group will grow by one on Sunday with the return of Dedniel Núñez. A breakout performer for the 2024 Mets, Núñez started the year in Triple A as he worked his way back from a season-ending elbow injury. Núñez will be recalled for the second game of New York's Sunday doubleheader in St. Louis, according to a league source. (Photo of Danny Young: Joe Robbins / Icon Sportswire via Getty Images)
